Senores Pharmaceuticals Limited (NSE:SENORES)
514.85
-0.25 (-0.05%)
Last updated: May 22, 2025
Senores Pharmaceuticals Company Description
Senores Pharmaceuticals Limited develops, manufactures, and sells, pharmaceutical products in India, the United States, Canada, and internationally.
The company offers tablets, capsules, liquids, dry syrups, oral rehydration solutions, active pharmaceutical ingredients, and critical care injectables, including antibiotics, anti-bacterial, anti-fungal, and blood line.
It also exports its products. The company provides consulting and licensing services.
Senores Pharmaceuticals Limited was incorporated in 2017 and is based in Ahmedabad, India.
Senores Pharmaceuticals Limited
Country | India |
Founded | 2017 |
Industry | Drug Manufacturers - General |
Sector | Healthcare |
Employees | 113 |
CEO | Swapnil Shah |
Contact Details
Address: 1101 To 1103, 11th floor Ahmedabad, Gujarat 380054 India | |
Phone | 91 79 2999 9857 |
Website | senorespharma.com |
Stock Details
Ticker Symbol | SENORES |
Exchange | National Stock Exchange of India |
Fiscal Year | April - March |
Reporting Currency | INR |
ISIN Number | INE0RB801010 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Swapnil Jatinbhai Shah | MD and Director |
Deval Rajnikant Shah | Whole-Time Director and Chief Financial Officer |
Chetan Bipinchandra Shah | Whole-Time Director and Chief Operating Officer |
Hanuwant Singh Shaktawat | Assistant Vice President of Human Resources and Admin |
Vinay Kumar Mishra | Company Secretary and Compliance Officer |
Deepak Jain | Vice President of Regulatory Affairs |